These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 29349519)

  • 1. Agonistic autoantibodies against adrenergic receptors correlating with antihypertensive therapy in long-standing diabetes type 2.
    Werner C; Müller N; Müller UA
    Acta Diabetol; 2018 Mar; 55(3):301-303. PubMed ID: 29349519
    [No Abstract]   [Full Text] [Related]  

  • 2. Correction to: Agonistic autoantibodies against adrenergic receptors correlating with antihypertensive therapy in long-standing diabetes type 2.
    Werner C; Müller N; Müller UA
    Acta Diabetol; 2019 Jul; 56(7):821. PubMed ID: 30957201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agonistic autoantibodies to the α(1) -adrenergic receptor and the β(2) -adrenergic receptor in Alzheimer's and vascular dementia.
    Karczewski P; Hempel P; Kunze R; Bimmler M
    Scand J Immunol; 2012 May; 75(5):524-30. PubMed ID: 22260197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoadsorption of Agonistic Autoantibodies Against α1-Adrenergic Receptors in Patients With Mild to Moderate Dementia.
    Hempel P; Heinig B; Jerosch C; Decius I; Karczewski P; Kassner U; Kunze R; Steinhagen-Thiessen E; Bimmler M
    Ther Apher Dial; 2016 Oct; 20(5):523-529. PubMed ID: 27096216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Positive rate of autoantibodies against adrenergic receptors beta1 and angiotensin II type 1 receptors in the type 2 diabetes mellitus with or without hypertension].
    Zhao LS; Liao YH; Xiang GD; Wang M; Yue L; Zhou ZH; Sun HL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Feb; 38(2):139-42. PubMed ID: 20398560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-CD38 autoantibodies: characterisation in new-onset type I diabetes and latent autoimmune diabetes of the adult (LADA) and comparison with other islet autoantibodies.
    Mallone R; Ortolan E; Pinach S; Volante M; Zanone MM; Bruno G; Baj G; Lohmann T; Cavallo-Perin P; Malavasi F
    Diabetologia; 2002 Dec; 45(12):1667-77. PubMed ID: 12488956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agonistic effects of anti-peptide antibodies and autoantibodies directed against adrenergic and cholinergic receptors: absence of desensitization.
    Wallukat G; Fu ML; Magnusson Y; Hjalmarson A; Hoebeke J; Wollenberger A
    Blood Press Suppl; 1996; 3():31-6. PubMed ID: 8973766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The relation between positive rate of autoantibodies against beta1 and M2-adrenergic receptors and urinary albumin excretion rate in the type 2 diabetes mellitus with refractory hypertension].
    Zhao LS; Liao YH; Xiang GD; Wang M; LE L; Zhou ZH; Lin X; Sun HL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Jun; 36(6):527-30. PubMed ID: 19100067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agonistic Autoantibodies to the β2-Adrenergic Receptor Involved in the Pathogenesis of Open-Angle Glaucoma.
    Jünemann A; Hohberger B; Rech J; Sheriff A; Fu Q; Schlötzer-Schrehardt U; Voll RE; Bartel S; Kalbacher H; Hoebeke J; Rejdak R; Horn F; Wallukat G; Kunze R; Herrmann M
    Front Immunol; 2018; 9():145. PubMed ID: 29483909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic and therapeutic aspects of β1-adrenergic receptor autoantibodies in human heart disease.
    Bornholz B; Roggenbuck D; Jahns R; Boege F
    Autoimmun Rev; 2014 Sep; 13(9):954-62. PubMed ID: 25149394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies against angiotensin and adrenergic receptors: more than a biomarker?
    Neuman R; Danser AHJ
    Clin Sci (Lond); 2018 Jan; 132(1):127-130. PubMed ID: 29326280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of autoantibodies against AT1 receptor and AGTR1 polymorphisms on candesartan-based antihypertensive regimen: results from the study of optimal treatment in hypertensive patients with anti-AT1-receptor autoantibodies trial.
    Sun Y; Liao Y; Yuan Y; Feng L; Ma S; Wei F; Wang M; Zhu F
    J Am Soc Hypertens; 2014 Jan; 8(1):21-7. PubMed ID: 24131669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study of autoantibodies against the G-protein-coupled beta 2- and alpha 1-adrenergic and AT1 receptors in patients with primary hypertension].
    Zhang L; Cui L; Miao GB; Zhao WS; Wang SY; Liu XL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Aug; 24(4):367-9. PubMed ID: 12905654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies against β1 receptor and AT1 receptor in type 2 diabetes patients with left ventricular dilatation.
    Zhao L; Xu C; Xu J
    Cardiology; 2014; 129(3):191-6. PubMed ID: 25323488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies against the myocardial beta1-adrenergic and M2-muscarinic receptors in patients with congestive heart failure.
    Zhang L; Hu D; Li J; Wu Y; Liu X; Yang X
    Chin Med J (Engl); 2002 Aug; 115(8):1127-31. PubMed ID: 12215275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sera from patients with type 2 diabetes contain agonistic autoantibodies against G protein-coupled receptors.
    Hempel P; Karczewski P; Kohnert KD; Raabe J; Lemke B; Kunze R; Bimmler M
    Scand J Immunol; 2009 Aug; 70(2):159-60. PubMed ID: 19630922
    [No Abstract]   [Full Text] [Related]  

  • 17. [Role of Autoantibodies Against 1-Adrenergic Receptor in Cardiovascular Disease].
    Kostyukevich MV; Zykov KA; Mironova NA; Agapova OY; Shevelev AY; Efremov EE; Vlasik TN; Golitsyn SP
    Kardiologiia; 2016 Dec; 56(12):82-91. PubMed ID: 28290809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to β adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome.
    Loebel M; Grabowski P; Heidecke H; Bauer S; Hanitsch LG; Wittke K; Meisel C; Reinke P; Volk HD; Fluge Ø; Mella O; Scheibenbogen C
    Brain Behav Immun; 2016 Feb; 52():32-39. PubMed ID: 26399744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of common β1-adrenergic receptor polymorphisms on the interaction with agonistic autoantibodies in dilated cardiomyopathy.
    Bornholz B; Hanzen B; Reinke Y; Felix SB; Boege F
    Int J Cardiol; 2016 Jul; 214():83-5. PubMed ID: 27057984
    [No Abstract]   [Full Text] [Related]  

  • 20. [Increased autoantibody production against AT(1)-receptors and alpha(1)-adrenergic receptors in hypertensive patients].
    Sun YX; Zhu F; Wang M; Li ZZ; Liao YH
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Jan; 36(1):16-9. PubMed ID: 19099920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.